PROCEPT BioRobotics (PRCT) Net Margin Growth (3y) (2023 - 2026)

PROCEPT BioRobotics (PRCT) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.90 Bn 176.61 Bn 6.27 Bn -388.00
2 Stryker 128.85 Bn 125.97 Bn 3.81 Bn -1.00
3 Medtronic 108.77 Bn 99.55 Bn 6.41 Bn -108.00
4 Boston Scientific 68.39 Bn 66.93 Bn 3.61 Bn 1,692.00
5 Edwards Lifesciences 48.50 Bn 44.83 Bn 1.29 Bn -
6 GE HealthCare Technologies 28.36 Bn 26.08 Bn 1.98 Bn 399.00
7 Dexcom 28.36 Bn 27.24 Bn 750.30 Mn 1,018.00
8 Smith & Nephew 26.92 Bn 26.35 Bn - -
9 Koninklijke Philips 25.48 Bn 22.35 Bn 2.07 Bn 1,978.00
10 PROCEPT BioRobotics 1.01 Bn 766.47 Mn 53.95 Mn 28,138.00

Historic Data

Download Data
DateValue
Mar 31, 2026 28,138.00
Dec 31, 2025 5,808.00
Sep 30, 2025 12,140.00
Jun 30, 2025 3,892.00
Mar 31, 2025 10,256.00
Dec 31, 2024 14,994.00
Sep 30, 2024 14,690.00
Jun 30, 2024 11,329.00
Mar 31, 2024 8,482.00
Dec 31, 2023 35,450.00
Sep 30, 2023 50,129.00